Login

Kyndryl CEO Martin Schroeter shared his insights on a significant day shortly after the Opening Bell. 00:10:00

Share On Facebook Share On Twitter

Martin J Schroeter is Chairman/CEO at Kyndryl Holdings Inc. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The Future of Small Caps: Concerns Over Regulatory Burdens and the Viability of Public Markets
00:10:00
Basic Game Theory Teaches Us About Startups|Michael Seibel,Managing Director, Early Stage and Group Partner,Y Combinator
00:10:00
Altitude Accelerator Expands with New Partnerships and Investor Readiness Program
00:10:00
Should You Buy or Rent a Home? Weighing Your Options | Michelle Smalenberger, CEO, Financial Design Studio.
00:10:00
An interview with Martin Klapdor, Senior Solution Architect at NETSCOUT, alongside insights from LangChain CEO Matthew on the future of AI agents.
00:10:00
Navigating Gold: Trends, Patterns, and Market Insights
00:10:00
Hope is not a strategy|Kevin Talbot,Co-Founder & Managing Partner,Relay Ventures
00:10:00
The Deal Economy - CEO Sam Riley | Sam Riley, CEO, Ansarada Group LtdAND:ASX
00:10:00
Streamlining Financial Planning Integration: Insights from John Pastore | Integrated Financial Partners
00:10:00
Condor Gold: Expanding High-Grade Gold Production in Nicaragua
00:10:00
One of the leading Israeli venture funds of the last decade|Adi Levanon,Founding Partner,Selah VC
00:10:00
Michael F Schein: What Punk Rock Teaches Us About Marketing | Mathieu Bonnet, CEO, Allego NVALLG:NYQ

© 2026 Nehu